• new product

Cicada Innovations launches HealthTech Hub in Western Sydney’s “hidden innovation ecosystem”

PRNewswire March 26, 2024

SYDNEY, March 26, 2024 /PRNewswire/ — Australia’s flagship deep tech incubator Cicada Innovations is officially opening the doors to the “Cicada HealthTech Hub” on 25 March 2024, officiated by the Hon. Anoulack Chanthivong, Minister for Innovation, Science and Technology.

(L-R) Hon. Anoulack Chanthivong, Minister for Innovation, Science and Technology, and Sally-Ann Williams, CEO of Cicada Innovations

The world-class incubation facility is supported by a grant from Investment NSW, and will be situated within one of Australia’s largest health and biomedical precincts, the Westmead Health and Innovation District, located in Sydney’s Western Suburbs.

Incubation is now open to pre-revenue stage startups, spinouts, research projects, and more established businesses looking for a landing pad in areas of medical technology and devices such as cell and gene therapy, cancer research, infectious diseases, immunology, and vaccines.

Benefits include affordable and flexible workspaces, dedicated facilities, critical connections, and curated support services, all aimed at facilitating the rapid commercialisation of life-changing research with real patient outcomes.

The first resident already on site is iiSheild, a healthtech startup whose groundbreaking “kidney pyjamas” (Ischemic Injury Protective Jacket) aim to double the available time for kidney transplants by minimising the heat of the kidney during procedures.

iiShield originated in Westmead then moved into Cicada Innovations’ Eveleigh site as it completed the Cicada-run NSW Health Commercialisation Training Program, then moved back to Westmead to be closer to precinct, progress clinical trials, and raise its next round of capital.

Residents like iiShield will benefit from being located in a district that boasts four major hospitals, four world-leading medical research institutions, two university campuses and the largest research-intensive pathology service in NSW.

Western Sydney more broadly also offers a rapidly-growing diverse population of 2.5 million people and over 1000 clinical trials including some of Australia’s biggest, while Australia’s first commercial-scale viral vector manufacturing facility is currently being built in the precinct.

All of these factors and more make Western Sydney one of Australia’s most critical “hidden innovation gems” according to Cicada Innovations CEO, Sally-Ann Williams.

Sally-Ann Williams, CEO of Cicada Innovations, said: “Western Sydney may not be the first location that springs to mind when we think ‘innovation’. But when you look at the groundbreaking work coming from the precinct, it really could be considered one of Australia’s most exciting hidden innovation gems.

“Companies like iiShield, originating in Westmead, offer a perfect case study of the journey Australia’s most critical medtech companies take from research lab to commercialisation to the homes and industries where they will positively impact the largest number of people.

“We’re excited to now be calling for many more iiShields to come and take advantage of these state-of-the art facilities and the many benefits the growing precinct has to offer.”

Hon. Anoulack Chanthivong, Minister for Innovation, Science and Technology said: “The HealthTech Hub will play a vital role in driving biotech, medtech and pharmaceutical industry development in NSW by bringing our world class health researchers and entrepreneurs together. It will support early-stage startups to build capability, fast-tracking commercialisation and helping to grow our state’s future skills pipeline.

“The Hub is a great example of how the NSW Government is working with organisations like Cicada to build a collaborative, inclusive and more supportive innovation ecosystem.”

Cicada Innovations will deliver the new health-focused program alongside Australasia’s leading life science VC firm, Brandon Capital.

Brandon Capital will also play a role in supporting commercial outcomes through participation in Cicada’s commercialisation programs, mentoring, and support for innovators in the precinct.

Cicada Innovations is urging all aspiring medtech founders and innovators to explore residency opportunities by leaving their details as an expression of interest here.

Cicada Innovations is the home of deep tech in Australia. Founded in Sydney, Cicada Innovations has a 23-year track record of developing deep tech ventures that tackle some of the world’s most pressing problems.           

Cicada’s national incubators, commercialisation training, and community brings together the entrepreneurs, scientists, business leaders, and policymakers to solve complex challenges with deep tech like the future of human health, food security and the climate crisis.         

Since its inception more than two decades ago, Cicada has seen an unprecedented $1.3 billion in exits from six deep tech ventures, and has helped over 300 companies raise more than $1.8 billion in funding. It has twice been named the ‘Top Incubator in the World’ by the International Business Innovation Association and has delivered commercialisation training to thousands working in the science and technology sectors.

Third Hemisphere is Cicada Innovations’ PR & Marketing Agency in Sydney



Cision View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/cicada-innovations-launches-healthtech-hub-in-western-sydneys-hidden-innovation-ecosystem-302098778.html

SOURCE Cicada Innovations

AAPR aggregates press releases and media statements from around the world to assist our news partners with identifying and creating timely and relevant news.

All of the press releases published on this website are third-party content and AAP was not involved in the creation of it. Read the full terms.